Recombinant Cryptococcus gattii serotype B Probable endonuclease LCL3 (LCL3)

Shipped with Ice Packs
In Stock

Description

Contextual Insights from Cryptococcal Genomics

While LCL3 is not described in available materials, Cryptococcus gattii serotype B has been extensively studied for its genetic diversity, virulence factors, and antifungal resistance mechanisms. Key genomic features include:

Table 1: Key Genetic Features of C. gattii Serotype B

FeatureDescriptionSource(s)
Molecular TypeVGII (predominant outbreak-associated clade)
Virulence FactorsCapsular polysaccharides, phospholipase B (PLB1), laccase (LAC1)
Antifungal SusceptibilityMore susceptible to azoles than serotype C isolates
Population StructureClonal expansion with limited recombination in outbreak strains

Endonuclease-Related Research in C. gattii

  • Mitochondrial genome stability: Serotype B shows minimal recombination in mitochondrial DNA compared to serotype C .

  • DNA repair genes: Genes like URA5 and SOD1 are critical in MLST typing but are unrelated to LCL3 .

Recombinant Protein Studies in Cryptococci

Recombinant protein expression in C. gattii has focused on:

  • Immunogenic proteins: GXM (glucuronoxylomannan) synthesis enzymes and capsule-associated proteins like CAP59 .

  • Enzymatic targets: Laccase (LAC1) and phospholipase B (PLB1) for virulence studies .

Recommendations for Further Investigation

To resolve the absence of LCL3-specific data:

  1. Database mining: Query UniProt, NCBI Protein, or FungiDB using the identifier "LCL3".

  2. Genome annotation tools: Analyze C. gattii VGII reference genomes (e.g., strains RMx0001 or R265) for hypothetical endonucleases.

  3. Functional studies: If LCL3 is a novel annotation, validate via:

    • CRISPR-Cas9 knockout in serotype B strains

    • Recombinant expression in E. coli or Pichia systems

Limitations of Current Data

The search results prioritize population genetics, antifungal responses, and outbreak epidemiology rather than specific enzymatic characterization. No studies discuss recombinant endonucleases in C. gattii serotype B.

Product Specs

Form
Lyophilized powder.
Note: While we prioritize shipping the format currently in stock, please specify your preferred format in order notes for fulfillment.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: Our proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to settle the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting to -20°C/-80°C. Our standard glycerol concentration is 50%, which may serve as a useful reference for your protocols.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer components, temperature, and protein stability. Generally, liquid forms have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. If you require a specific tag, please inform us; we will prioritize its development.
Synonyms
LCL3; CGB_D5120C; Probable endonuclease LCL3
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-286
Protein Length
full length protein
Species
Cryptococcus gattii serotype B (strain WM276 / ATCC MYA-4071) (Filobasidiella gattii) (Cryptococcus bacillisporus)
Target Names
LCL3
Target Protein Sequence
MSGSYSPQKDPQHPTQHQQFPPTPPYPSSSVWSGNLGENPVFIGIGSAAGASALTLLGVM GYRRYWKRIKNADYVTSELLRRRAWIKGIVTSVGDGDNLRLYHTPGPFFRYPFKIRSIPT TQKGLRNETISIRIAGVDAPENAHFGNPAQPHAKESLEWLRATILGKRMRCQLLAKDQYN RIVAVPYISRRLWWDRPLPLMMLKEGMAVVYKAGGAEYGPWGLDEMLKVEAEARDAKRGL WALRKFESPGDFKARMKLKSDVSEERPEKKSPSGWIALVKRLIRRT
Uniprot No.

Target Background

Database Links
Protein Families
LCL3 family
Subcellular Location
Mitochondrion. Membrane; Single-pass membrane protein.

Q&A

What is Cryptococcus gattii serotype B Probable endonuclease LCL3?

Probable endonuclease LCL3 is a protein encoded by the LCL3 gene in Cryptococcus gattii serotype B. The protein is classified as an endonuclease (EC 3.1.-.-), suggesting its probable role in nucleic acid metabolism. The full-length protein consists of 286 amino acids with a specific sequence beginning with MSGSYSPQKDPQHPTQHQQFPPTPPYPSSSVWSGNLGENPVFIGIGSAAGASALTLLGVM and continuing through the protein's structure . C. gattii is a pathogenic yeast that, together with Cryptococcus neoformans, causes cryptococcosis in humans and animals .

How does Cryptococcus gattii serotype B relate to other molecular types within the species?

Cryptococcus gattii is classified into four major molecular types: VGI, VGII, VGIII, and VGIV. This classification has been standardized by the International Society for Human and Animal Mycology (ISHAM) working group to enable global tracking of strains . The strain WM276 (ATCC MYA-4071), from which the recombinant LCL3 is typically derived, is a VGI molecular type . This typing is significant because different molecular types show different epidemiological patterns, virulence characteristics, and genetic exchange behaviors. For instance, VGI populations tend to be strongly clonal, while VGII populations show evidence of sexual recombination .

What are the typical storage and handling conditions for recombinant LCL3 protein?

Recombinant LCL3 protein is typically stored in a Tris-based buffer with 50% glycerol optimized for protein stability. For long-term storage, the protein should be kept at -20°C or -80°C. Working aliquots can be maintained at 4°C for up to one week. Repeated freezing and thawing should be avoided to maintain protein integrity and activity . When designing experiments, researchers should consider these storage parameters to ensure consistent protein performance across studies.

What are the potential research applications for recombinant LCL3 in studying C. gattii pathogenesis?

As a probable endonuclease, LCL3 may be involved in DNA processing mechanisms that contribute to C. gattii's virulence or survival within host cells. Researchers can use the recombinant protein to investigate:

  • DNA repair mechanisms during host-pathogen interactions

  • Potential roles in recombination processes, particularly relevant since C. gattii VGII shows evidence of sexual recombination in nature

  • Comparative studies between different C. gattii molecular types to understand functional differences that might correlate with epidemiological patterns

  • Structure-function relationships to identify potential targets for antifungal development

Experimental approaches might include in vitro nuclease activity assays, protein-DNA interaction studies, and comparative analyses with homologous proteins from other Cryptococcus species.

How should researchers design control experiments when studying LCL3 enzymatic activity?

When investigating the enzymatic activity of recombinant LCL3, researchers should implement the following controls:

  • Negative controls with heat-inactivated LCL3 to confirm that observed nuclease activity is specific to the active protein

  • Substrate specificity controls using different DNA/RNA structures to characterize enzymatic preferences

  • Comparative assays with known endonucleases to benchmark activity levels

  • Chelation experiments with EDTA or other metal ion chelators to determine if LCL3 is a metal-dependent endonuclease

  • pH and salt concentration gradients to determine optimal reaction conditions

These controls will help differentiate between specific enzymatic activities and non-specific interactions or contamination effects.

What considerations should be made when comparing LCL3 from different C. gattii molecular types?

When conducting comparative studies of LCL3 across different C. gattii molecular types, researchers should consider:

  • Sequence variations: Different molecular types (VGI, VGII, VGIII, VGIV) may have allelic variations in the LCL3 gene that could affect protein function

  • Expression patterns: Transcriptomic studies have revealed that different subtypes (e.g., VGIIa and VGIIb) employ different transcriptional circuits despite similar genomes

  • Standardized typing: Use the ISHAM consensus MLST typing scheme, which includes seven genetic loci (CAP59, GPD1, LAC1, PLB1, SOD1, URA5, and the IGS1 region) for proper strain classification

  • Geographic variation: Consider the geographic origin of isolates, as genetic differentiation exists between populations from different regions

A comprehensive comparison should include both sequence analysis and functional characterization to correlate genetic differences with enzymatic activity variations.

How might LCL3 contribute to the genetic recombination observed in VGII populations of C. gattii?

Studies have demonstrated that VGII populations of C. gattii show evidence of sexual recombination in nature, while VGI populations tend to be clonal . As a probable endonuclease, LCL3 might play a role in this recombination process. Researchers investigating this connection should consider:

  • Whether LCL3 expression or activity differs between recombining and clonal populations

  • The potential role of LCL3 in processing DNA during meiotic recombination

  • Whether sequence variations in LCL3 correlate with the recombination capability of different molecular types

  • Possible interactions between LCL3 and other proteins involved in mating and meiosis

Experimental approaches might include gene knockout or knockdown studies, protein-protein interaction analyses, and comparative genomics across different molecular types with varying recombination capabilities.

What is the relationship between LCL3 function and virulence in different C. gattii molecular types?

Different molecular types of C. gattii show variations in virulence patterns. For example, VGII has been associated with severe lung disease, while C. neoformans more commonly causes central nervous system infections . Investigating whether LCL3 contributes to these virulence differences could involve:

  • Comparing LCL3 sequence, expression, and activity across strains with different virulence profiles

  • Evaluating LCL3's potential role in stress responses during host infection

  • Assessing whether LCL3 contributes to DNA repair following host-induced oxidative damage

  • Investigating potential non-canonical functions beyond its predicted endonuclease activity

This research would require a combination of in vitro biochemical assays, cell culture infection models, and potentially animal studies to fully characterize the relationship between LCL3 and virulence.

How do post-translational modifications affect LCL3 activity in different environmental conditions?

For researchers investigating regulatory mechanisms controlling LCL3 function:

  • Identify potential post-translational modification sites in the LCL3 sequence using bioinformatic tools

  • Compare modifications across different growth conditions that mimic various host environments

  • Assess how modifications affect enzymatic activity, localization, and protein-protein interactions

  • Investigate the signaling pathways responsible for inducing these modifications during infection

Mass spectrometry-based proteomics approaches would be essential for mapping modifications, while site-directed mutagenesis of modification sites would help determine their functional significance.

What are the optimal conditions for assaying LCL3 endonuclease activity in vitro?

When establishing an in vitro assay for LCL3 endonuclease activity, researchers should consider:

  • Buffer composition: Test various buffering systems (Tris, HEPES, phosphate) at pH ranges from 6.0 to 8.5

  • Ionic strength: Evaluate activity across NaCl concentrations from 0-200 mM

  • Divalent cation requirements: Test Mg²⁺, Mn²⁺, Ca²⁺, and Zn²⁺ at concentrations from 1-10 mM

  • Temperature: Assess activity at 25°C, 30°C, and 37°C

  • Substrate specificity: Use various DNA structures (linear, circular, single-stranded, double-stranded, specific sequences)

A systematic approach involving these parameters will help establish optimal conditions for reliable enzyme activity measurements.

How can researchers effectively compare LCL3 variants from different C. gattii isolates?

For researchers investigating LCL3 diversity across C. gattii strains:

  • Use the standardized MLST typing scheme to accurately classify isolates

  • Sequence the LCL3 gene from multiple isolates representing each molecular type (VGI, VGII, VGIII, VGIV)

  • Express and purify recombinant variants under identical conditions

  • Perform side-by-side enzymatic assays under standardized conditions

  • Conduct structural analyses to correlate sequence differences with functional variations

This approach allows for systematic comparison while controlling for experimental variables that might confound results.

What techniques are most effective for studying LCL3 localization and dynamics during C. gattii infection?

To investigate LCL3 behavior during infection, researchers should consider:

  • Generating fluorescently tagged LCL3 constructs for live-cell imaging

  • Using fractionation techniques to track LCL3 distribution across cellular compartments

  • Employing immunofluorescence with specific antibodies against LCL3

  • Developing cell culture infection models that allow real-time monitoring

  • Combining these approaches with inhibitor studies to link localization changes with functional outcomes

Time-course experiments during infection would be particularly valuable in understanding dynamic changes in LCL3 behavior during host-pathogen interactions.

What are the key challenges in studying LCL3 function in the context of C. gattii molecular diversity?

Researchers face several challenges when investigating LCL3 across different C. gattii molecular types:

  • Genetic manipulation difficulties: Developing consistent transformation protocols across diverse strains

  • Environmental relevance: Replicating natural conditions where different molecular types thrive

  • Population structure: Accounting for both clonal and recombining population dynamics

  • Geographic diversity: Managing isolate collections from diverse locations where genetic differentiation has been observed

  • Variability in mating capability: Addressing differences in sexual reproduction between molecular types that might affect LCL3 function

Addressing these challenges requires collaborative approaches and standardized methodologies across research groups.

How might structural biology approaches advance our understanding of LCL3 function?

Structural biology techniques offer powerful tools for understanding LCL3:

  • X-ray crystallography or cryo-EM to determine the three-dimensional structure

  • Hydrogen-deuterium exchange mass spectrometry to identify flexible regions and binding interfaces

  • Molecular dynamics simulations to understand conformational changes during substrate binding

  • Structure-guided mutagenesis to validate functional predictions

  • Comparative structural analysis with homologous endonucleases from other fungi

These approaches would provide insights into the catalytic mechanism and potentially reveal unique structural features that could be targeted for antifungal development.

What emerging technologies might enhance research on LCL3 and its role in C. gattii biology?

Emerging technologies with potential applications in LCL3 research include:

  • CRISPR-Cas9 gene editing for precise manipulation of LCL3 in various C. gattii strains

  • Single-cell RNA sequencing to understand LCL3 expression heterogeneity during infection

  • Proximity labeling techniques to identify LCL3 interaction partners in vivo

  • High-throughput screening platforms to identify inhibitors specific to fungal endonucleases

  • Advanced imaging techniques such as super-resolution microscopy for tracking LCL3 dynamics at the nanoscale

Integrating these technologies into research programs would accelerate discoveries about LCL3's biological significance and potential as a therapeutic target.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.